Omeprazole and calcium carbonate drug interactions
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole and Calcium Carbonate Drug Interactions: Key Findings
Effect of Omeprazole on Calcium Carbonate as a Phosphate Binder
Several studies have examined whether omeprazole, a proton pump inhibitor, affects the ability of calcium carbonate to act as a phosphate binder, especially in patients with chronic kidney disease or those on hemodialysis. The majority of research indicates that omeprazole does not significantly reduce the phosphate-binding efficiency of calcium carbonate in these patients. Both clinical trials and crossover studies in hemodialysis patients found that co-administration of omeprazole did not lead to a significant increase in plasma phosphate levels, suggesting that calcium carbonate remains effective as a phosphate binder even when gastric acid secretion is inhibited by omeprazole Aboelyazeed2017Sechet1999Hardy1998.
Omeprazole and Calcium Absorption from Calcium Carbonate
While omeprazole does not seem to impact phosphate binding, it does appear to reduce the intestinal absorption of calcium from calcium carbonate. In studies involving healthy adults and postmenopausal women, the use of omeprazole significantly lowered the rise in serum calcium levels after ingestion of calcium carbonate, indicating reduced calcium absorption. This effect was not observed with other forms of calcium, such as soluble fiber-enriched milk, which suggests that the reduced stomach acidity caused by omeprazole specifically impairs the dissolution and absorption of calcium carbonate 3Oliveira2017.
Clinical Implications for Patients
For patients using calcium carbonate as a phosphate binder, especially those on hemodialysis, omeprazole does not appear to compromise phosphate control. However, for individuals relying on calcium carbonate for calcium supplementation, omeprazole may reduce the effectiveness of this supplement by decreasing calcium absorption. This could be particularly relevant for populations at risk of osteoporosis or with increased calcium needs, such as postmenopausal women Aboelyazeed2017Sechet19993+2 MORE.
Conclusion
In summary, omeprazole does not significantly interfere with the phosphate-binding action of calcium carbonate in patients with kidney disease, but it can reduce the absorption of calcium from calcium carbonate supplements. Patients who require both medications should be aware of this interaction, especially if calcium supplementation is critical for their health.
Sources and full results
Most relevant research papers on this topic
[Inhibition of gastric secretion by omeprazole and efficacy of calcium carbonate in the control of hyperphosphatemia in patients on maintenance hemodialysis].
Inhibiting gastric secretion by omeprazole does not decrease calcium carbonate's efficiency as a phosphate binder in patients on maintenance hemodialysis.
Acute Effects Of Oral Calcium Carbonate With And Without The Addition Of Omeprazole And Fiber Enriched Milk On Serum Calcium Concentrations In Postmenopausal Women
Omeprazole significantly reduced the intestinal absorption of calcium carbonate, leading to a lower serum calcium response compared to soluble fiber enriched milk.
Effect of omeprazole on antihypertensive efficacy of amlodipine in patients with comorbid pathology – arterial hypertension and acid-dependent disease
Omeprazole addition to amlodipine-based antihypertensive therapy significantly reduces systolic and diastolic arterial pressure in patients with arterial hypertension and acid-dependent diseases.
DOI